SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640455-21-000016
Filing Date
2021-01-22
Accepted
2021-01-22 18:35:57
Documents
1
Period of Report
2021-01-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161135854303039.html 4  
1 FORM 4 wf-form4_161135854303039.xml 4 21761
  Complete submission text file 0001640455-21-000016.txt   23142
Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Drapkin Kimberlee C (Reporting) CIK: 0001340881 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 21547394

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)